Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Drug Therapy for Rheumatoid Arthritis in Adults

Slides: 1–12 of 45
Add to tray Remove from tray

Drug Therapy for Rheumatoid Arthritis in Adults

Add to tray Remove from tray

Outline of Material

Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral
Add to tray Remove from tray

Health Impact of Rheumatoid Arthritis

Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | prevalence
Add to tray Remove from tray

Treatment of Rheumatoid Arthritis

Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | corticosteroids
Add to tray Remove from tray

DMARDs in Rheumatoid Arthritis Treatment (1 of 2)

Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral
Add to tray Remove from tray

DMARDs in Rheumatoid Arthritis Treatment (2 of 2)

Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | cytokines | TNF-alpha | tumor necrosis factor-alpha | interleukin 1 | IL-1 | interleukin 6 | IL-6 | CD20 | CD28
Add to tray Remove from tray

Oral DMARDs Included in the Comparative Effectiveness Review

Keywords: anti-rheumatic | antirheumatic | biologic | cytokine synthesis | dihydrofolate reductase | disease-modifying | DMARDs | folate metabolism | hydroxychloroquine | leflunomide | lymphocyte function | methotrexate | oral | pyridine synthesis | RA | rheumatic | sulfasalazine | T-lymphocytes | rheumatoid arthritis
Add to tray Remove from tray

Biologic DMARDs Included in the Comparative Effectiveness Review

Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | tumor necrosis factor-alpha | TNF-alpha | TNF-a | adalimumab | etanercept | infliximab | abatacept | anakinra | rituximab | tocilizumab
Add to tray Remove from tray

Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development

Keywords: comparative effectiveness review | systematic review
Add to tray Remove from tray

Rating the Strength of Evidence From the Comparative Effectiveness Review

Keywords: strength of evidence | comparative effectiveness
Add to tray Remove from tray

Clinical Questions Addressed by the Comparative Effectiveness Review

Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | demographics | comorbidities
Add to tray Remove from tray

Clinically Significant Outcomes of Interest in the Comparative Effectiveness Review

Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | disease activity | ACR | radiographic evidence of progression | functional capacity | HAQ | quality of life | SF-36 | DAS
Pages: [1] 2 3 4 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364